Commodore Capital’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-565,000
| Closed | -$13.2M | – | 40 |
|
|
2023
Q4 | $13.2M | Hold |
565,000
| – | – | 1.15% | 25 |
|
|
2023
Q3 | $28.6M | Sell |
565,000
-1,110,000
| -66% | -$56.1M | 3.34% | 13 |
|
|
2023
Q2 | $78.2M | Buy |
1,675,000
+885,000
| +112% | +$41.3M | 8.79% | 3 |
|
|
2023
Q1 | $30.2M | Buy |
790,000
+252,924
| +47% | +$9.68M | 4.6% | 8 |
|
|
2022
Q4 | $29.4M | Sell |
537,076
-206,396
| -28% | -$11.3M | 4.44% | 8 |
|
|
2022
Q3 | $25.3M | Buy |
+743,472
| New | +$25.3M | 4.07% | 8 |
|